Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Dec. 5 (Bloomberg) -- Perrigo Inc. climbed the most since September as the manufacturer of over-the-counter pharmaceuticals was rated “buy” in new coverage at UBS AG.

The shares rose 4.8 percent, the most since Sept. 15, to 234.5 shekels at the 4:30 p.m. close in Tel Aviv.

UBS set a share-price estimate of $72. The shares gained 2 percent to $64.12 in U.S. trading on Dec. 3.

To contact the reporter on this story: Claudia Maedler in Dubai at

To contact the editor responsible for this story: Shanthy Nambiar at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.